πŸ“ˆ LEMMING INVESTOR RESEARCH by πŸ“ˆSmall Company Champion

πŸ“ˆ LEMMING INVESTOR RESEARCH by πŸ“ˆSmall Company Champion

Share this post

πŸ“ˆ LEMMING INVESTOR RESEARCH by πŸ“ˆSmall Company Champion
πŸ“ˆ LEMMING INVESTOR RESEARCH by πŸ“ˆSmall Company Champion
Poolbeg Pharma Plc

Poolbeg Pharma Plc

Scientific Advisory Board's Endorsement Boosts Credibility of AI-Led Influenza Drug Discovery Program

🐝 Elric Langton's avatar
🐝 Elric Langton
Oct 26, 2023
βˆ™ Paid

Share this post

πŸ“ˆ LEMMING INVESTOR RESEARCH by πŸ“ˆSmall Company Champion
πŸ“ˆ LEMMING INVESTOR RESEARCH by πŸ“ˆSmall Company Champion
Poolbeg Pharma Plc
Share
Poolbeg Pharma PLC (AIM:POLB) Artificial Intelligence deal signed with  CytoReason – Share Talk

By Elric Langton and Alex Langton | 26 October 2023

I have a financial interest in Poolbeg Pharma

Poolbeg Pharma, a forward-thinking clinical-stage biopharmaceutical company dedicated to addressing diseases with a significant unmet medical need, announced its Scientific Advisory Board (SAB) has endorsed the influenza drug targets uncovered through Poolbeg’s innovative AI-driven drug discovery program. Of course, the bullet board experts seem to have ignored critical aspects of today’s announcement, instead focussing on the fact that the Company’s in-house SAB endorsed the identified influenza drug targets. I will come back to this later.

This post is for paid subscribers

Already a paid subscriber? Sign in
Β© 2025 πŸ“ˆ 🐝 Small Company Champion - Small Company Media Ltd
Privacy βˆ™ Terms βˆ™ Collection notice
Start writingGet the app
Substack is the home for great culture

Share